| - GRCh37:
- ChrX:100656707
- GRCh38:
- ChrX:101401719
| GLA, RPL36A-HNRNPH2 | I154V, I195V | Fabry disease | Benign (Apr 5, 2023) | no assertion criteria provided |
| - GRCh37:
- ChrX:100653778
- GRCh38:
- ChrX:101398790
| GLA, RPL36A-HNRNPH2 | D266N | Fabry disease | Pathogenic (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653038
- GRCh38:
- ChrX:101398050
| GLA, RPL36A-HNRNPH2 | A350V, A391V | Fabry disease | Uncertain significance (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653795
- GRCh38:
- ChrX:101398807
| GLA, RPL36A-HNRNPH2 | G260V, G301V | Fabry disease | Likely pathogenic (Feb 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100651964-100653826
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655634-100656817
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Pathogenic (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100499986-100662891
| BTK, DRP2, GLA, RPL36A, RPL36A-HNRNPH2, TAF7L, TIMM8A | | Fabry disease | Pathogenic (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655754
- GRCh38:
- ChrX:101400766
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653346
- GRCh38:
- ChrX:101398358
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652940
- GRCh38:
- ChrX:101397952
| GLA, RPL36A-HNRNPH2 | F383L, F424L | Fabry disease | Uncertain significance (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652933
- GRCh38:
- ChrX:101397945
| GLA, RPL36A-HNRNPH2 | T426I, T385I | Fabry disease | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100663464
- GRCh38:
- ChrX:101408476
| GLA, HNRNPH2, RPL36A-HNRNPH2 | | Fabry disease | Uncertain significance (Jul 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652977
- GRCh38:
- ChrX:101397989
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653102
- GRCh38:
- ChrX:101398114
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662887
- GRCh38:
- ChrX:101407899
| GLA, RPL36A-HNRNPH2 | Q2R | Fabry disease | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662867
- GRCh38:
- ChrX:101407879
| GLA, RPL36A-HNRNPH2 | H9Y | Fabry disease | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653784
- GRCh38:
- ChrX:101398796
| GLA, RPL36A-HNRNPH2 | D305N, D264N | Fabry disease | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662874
- GRCh38:
- ChrX:101407886
| RPL36A-HNRNPH2, GLA | | Fabry disease | Likely benign (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658953
- GRCh38:
- ChrX:101403965
| GLA, RPL36A-HNRNPH2 | M72T, M113T | Fabry disease | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662860
- GRCh38:
- ChrX:101407872
| GLA, RPL36A-HNRNPH2 | G11fs | Fabry disease | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662848
- GRCh38:
- ChrX:101407860
| GLA, RPL36A-HNRNPH2 | A15E | Fabry disease | Pathogenic (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662774
- GRCh38:
- ChrX:101407786
| GLA, RPL36A-HNRNPH2 | P40A | Fabry disease | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662755
- GRCh38:
- ChrX:101407767
| GLA, RPL36A-HNRNPH2 | H46P | Fabry disease | Likely pathogenic (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658941
- GRCh38:
- ChrX:101403953
| GLA, RPL36A-HNRNPH2 | M76T, M117T | Fabry disease | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658867
- GRCh38:
- ChrX:101403879
| GLA, RPL36A-HNRNPH2 | D101N, D142N | Fabry disease | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658810
- GRCh38:
- ChrX:101403822
| GLA, RPL36A-HNRNPH2 | L161V, L120V | Fabry disease | Likely pathogenic (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656741
- GRCh38:
- ChrX:101401753
| GLA, RPL36A-HNRNPH2 | C183*, C142* | Fabry disease | Pathogenic (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655682
- GRCh38:
- ChrX:101400694
| GLA, RPL36A-HNRNPH2 | W204* | Fabry disease, not provided | Pathogenic (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:100653811-100653813
- GRCh38:
- ChrX:101398823-101398825
| GLA, RPL36A-HNRNPH2 | V295del, V254del | Fabry disease | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653512
- GRCh38:
- ChrX:101398524
| GLA, RPL36A-HNRNPH2 | T323N, T282N | Fabry disease | Uncertain significance (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653486
- GRCh38:
- ChrX:101398498
| GLA, RPL36A-HNRNPH2 | A291T | Fabry disease | Likely pathogenic (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653411
- GRCh38:
- ChrX:101398423
| GLA, RPL36A-HNRNPH2 | V316I | Fabry disease | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653374
- GRCh38:
- ChrX:101398386
| GLA, RPL36A-HNRNPH2 | G369E, G328E | Fabry disease | Likely pathogenic (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653068
- GRCh38:
- ChrX:101398080
| GLA, RPL36A-HNRNPH2 | W340* | Fabry disease | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652848
- GRCh38:
- ChrX:101397860
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656637
- GRCh38:
- ChrX:101401649
| GLA, RPL36A-HNRNPH2 | L177W, L218W | Fabry disease | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653481
- GRCh38:
- ChrX:101398493
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662691
- GRCh38:
- ChrX:101407703
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655720
- GRCh38:
- ChrX:101400732
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662871
- GRCh38:
- ChrX:101407883
| GLA, RPL36A-HNRNPH2 | E7D | Fabry disease | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658839
- GRCh38:
- ChrX:101403851
| RPL36A-HNRNPH2, GLA | P151R, P110R | Fabry disease | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662697
- GRCh38:
- ChrX:101407709
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653490
- GRCh38:
- ChrX:101398502
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655750
- GRCh38:
- ChrX:101400762
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653875
- GRCh38:
- ChrX:101398887
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662863
- GRCh38:
- ChrX:101407875
| GLA, RPL36A-HNRNPH2 | L10P | Fabry disease | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655720
- GRCh38:
- ChrX:101400732
| GLA, RPL36A-HNRNPH2 | N192fs | Fabry disease | Pathogenic (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652818
- GRCh38:
- ChrX:101397830
| GLA, RPL36A-HNRNPH2 | M423I, M464I | Fabry disease | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652816
- GRCh38:
- ChrX:101397828
| GLA, RPL36A-HNRNPH2 | S424*, S465* | Fabry disease | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653389
- GRCh38:
- ChrX:101398401
| GLA, RPL36A-HNRNPH2 | P323L, P364L | Fabry disease | Uncertain significance (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653442
- GRCh38:
- ChrX:101398454
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653514-100653515
- GRCh38:
- ChrX:101398526-101398527
| GLA, RPL36A-HNRNPH2 | T282fs | Fabry disease | Pathogenic (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662783
- GRCh38:
- ChrX:101407795
| GLA, RPL36A-HNRNPH2 | A37fs | Fabry disease | Pathogenic (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652992-100652993
- GRCh38:
- ChrX:101398004-101398005
| GLA, RPL36A-HNRNPH2 | Y365* | Fabry disease | Pathogenic (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653500
- GRCh38:
- ChrX:101398512
| GLA, RPL36A-HNRNPH2 | L286P, L327P | Fabry disease | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653373
- GRCh38:
- ChrX:101398385
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652947
- GRCh38:
- ChrX:101397959
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Jun 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658871
- GRCh38:
- ChrX:101403883
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658827
- GRCh38:
- ChrX:101403839
| GLA, RPL36A-HNRNPH2 | P114L, P155L | Fabry disease | Uncertain significance (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653775
- GRCh38:
- ChrX:101398787
| GLA, RPL36A-HNRNPH2 | M267V, M308V | Fabry disease | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653087
- GRCh38:
- ChrX:101398099
| GLA, RPL36A-HNRNPH2 | G334R, G375R | Fabry disease | Uncertain significance (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662819
- GRCh38:
- ChrX:101407831
| GLA, RPL36A-HNRNPH2 | D25Y | Fabry disease | Uncertain significance (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653030
- GRCh38:
- ChrX:101398042
| GLA, RPL36A-HNRNPH2 | M353V, M394V | Fabry disease | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652920
- GRCh38:
- ChrX:101397932
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662860
- GRCh38:
- ChrX:101407872
| GLA, RPL36A-HNRNPH2 | G11A | Fabry disease | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655726
- GRCh38:
- ChrX:101400738
| GLA, RPL36A-HNRNPH2 | L189F | Fabry disease | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656784
- GRCh38:
- ChrX:101401796
| GLA, RPL36A-HNRNPH2 | G128E, G169E | Fabry disease | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656793
- GRCh38:
- ChrX:101401805
| GLA, RPL36A-HNRNPH2 | H125L, H166L | Fabry disease | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655669
- GRCh38:
- ChrX:101400681
| GLA, RPL36A-HNRNPH2 | M249I, M208I | Cardiovascular phenotype, Fabry disease | Uncertain significance (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:100662845
- GRCh38:
- ChrX:101407857
| GLA, RPL36A-HNRNPH2 | L16P | Cardiovascular phenotype, Fabry disease | Likely pathogenic (Mar 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:100658795
- GRCh38:
- ChrX:101403807
| GLA, RPL36A-HNRNPH2 | | Cardiovascular phenotype, Fabry disease | Uncertain significance (Jul 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:100658837-100658838
- GRCh38:
- ChrX:101403849-101403850
| GLA, RPL36A-HNRNPH2 | Q111fs | Fabry disease | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658849-100658850
- GRCh38:
- ChrX:101403861-101403862
| GLA, RPL36A-HNRNPH2 | Q107fs | Fabry disease | Likely pathogenic (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658863-100658864
- GRCh38:
- ChrX:101403875-101403876
| GLA, RPL36A-HNRNPH2 | S102fs | Fabry disease | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658870
- GRCh38:
- ChrX:101403882
| GLA, RPL36A-HNRNPH2 | R100fs | Fabry disease | Likely pathogenic (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662737-100662738
- GRCh38:
- ChrX:101407749-101407750
| GLA, RPL36A-HNRNPH2 | C52fs | Fabry disease | Likely pathogenic (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653050
- GRCh38:
- ChrX:101398062
| GLA, RPL36A-HNRNPH2 | G346A, G387A | Fabry disease | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653359
- GRCh38:
- ChrX:101398371
| RPL36A-HNRNPH2, GLA | Q333L, Q374L | Fabry disease | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653421
- GRCh38:
- ChrX:101398433
| GLA, RPL36A-HNRNPH2 | Q312H, Q353H | Fabry disease | Pathogenic (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655680
- GRCh38:
- ChrX:101400692
| GLA, RPL36A-HNRNPH2 | P205A, P246A | not provided, Fabry disease | Conflicting interpretations of pathogenicity (Sep 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:100652897
- GRCh38:
- ChrX:101397909
| GLA, RPL36A-HNRNPH2 | Y397C | Fabry disease | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653866
- GRCh38:
- ChrX:101398878
| GLA, RPL36A-HNRNPH2 | W236* | Fabry disease | Likely pathogenic (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653792
- GRCh38:
- ChrX:101398804
| GLA, RPL36A-HNRNPH2 | G261fs | Fabry disease | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658792
- GRCh38:
- ChrX:101403804
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658865
- GRCh38:
- ChrX:101403877
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (May 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658910
- GRCh38:
- ChrX:101403922
| RPL36A-HNRNPH2, GLA | | Fabry disease | Likely benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100662811
- GRCh38:
- ChrX:101407823
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Dec 7, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653046
- GRCh38:
- ChrX:101398058
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658967
- GRCh38:
- ChrX:101403979
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655636
- GRCh38:
- ChrX:101400648
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Nov 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656815-100656816
- GRCh38:
- ChrX:101401827-101401828
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653070
- GRCh38:
- ChrX:101398082
| RPL36A-HNRNPH2, GLA | | Fabry disease | Likely benign (Jul 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100655647
- GRCh38:
- ChrX:101400659
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Jun 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100656612
- GRCh38:
- ChrX:101401624
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658931
- GRCh38:
- ChrX:101403943
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658916
- GRCh38:
- ChrX:101403928
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Nov 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653926
- GRCh38:
- ChrX:101398938
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Nov 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100658877
- GRCh38:
- ChrX:101403889
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100652974
- GRCh38:
- ChrX:101397986
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Sep 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:100653950
- GRCh38:
- ChrX:101398962
| GLA, RPL36A-HNRNPH2 | | Fabry disease | Likely benign (Mar 11, 2021) | criteria provided, single submitter |